Q03164 (KMT2A_HUMAN) Homo sapiens (Human)

Histone-lysine N-methyltransferase 2A UniProtKBInterProSTRINGInteractive Modelling

3969 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3)

Available Structures

MLL cleavage product N320 1-2718; PRO_0000390949

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of MLL1 PHD3-Bromo complexed with H3(1-9)K4me3 peptide Heteromer
P68431;
1566-1779
ZN;
Assess
Crystal structure of MLL1 PHD3-Bromo complexed with H3(1-9)K4me2 peptide Heteromer
P68431;
1566-1778
ZN;
Assess
Complex Cyp33-RRM : MLL1-PHD3 Heteromer
Q9UNP9;
1564-1627
ZN;
Assess
Trimolecular complex Cyp33-RRMdelta alpha : MLL1-PHD3 : H3K4me3 Heteromer
Q6NXT2; Q9UNP9;
1564-1627
ZN;
Assess
Crystal structure of human menin in complex with MLL1 and LEDGF Heteromer
O00255; O75475;
103-135
CHD;GGB;0BR;GLV;SO4;
Assess
Solution structure of LEDGF/p75 IBD in complex with MLL1 peptide (140-160) Heteromer
O75475;
140-160
Assess
Human menin in complex with MLL peptide Heteromer
O00255;
6-15
SO4;1PE;
Assess
STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH SYNTHETIC PHOSPHONO-MLL PEPTIDE ANALOG Heteromer
P01889; P61769;
747-755
GOL;NA;
Assess
STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH SYNTHETIC SULFO-MLL PEPTIDE ANALOG Heteromer
P01889; P61769;
747-755
GOL;
Assess
STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PHOSPHOPEPTIDE AND BOUND GLYCEROL Heteromer
P01889; P61769;
747-755
GOL;
Assess
STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PEPTIDE AND BOUND GLYCEROL Heteromer
P01889; P61769;
747-755
GOL;
Assess
CRYSTAL STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PHOSPHOPEPTIDE Heteromer
P01889; P61769;
747-755
GLC;
Assess
CRYSTAL STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PEPTIDE Heteromer
P01889; P61769;
747-755
GOL;CL;NA;
Assess
STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PHOSPHOPEPTIDE, CUBIC CRYSTAL FORM Heteromer
P01889; P61769;
747-755
12P;PE8;PGE;PEG;PG4;ACT;1PE;
Assess
Crystal structure of human menin in complex with MLL1 Heteromer
O00255;
6-13
Assess
Crystal structure of MLL1 PHD3-Bromo in the free formmonomer1566-1778
ZN;
Assess
Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histoneā€¦monomer1143-1214
ZN;
Assess
The solution structure of the PHD3 finger of MLLmonomer1564-1628
ZN;
Assess
Solution structure of MLL CXXC domain in complex with palindromic CPG DNAmonomer1147-1203
ZN;
Assess
Solution structure of MLL CXXC domainmonomer1147-1203
ZN;
Assess
Crystal structure of MLL CXXC domain in complex with a CpG DNAmonomer1150-1200
ZN;
Assess
Solution structure of the LEDGF/p75 IBD - MLL1 (aa 111-160) complexmonomer111-160
Assess
Solution structure of MLL1 PHD3-Cyp33 RRM chimeric proteinmonomer1585-1628
Assess
Solution structure of MLL-IBD complexmonomer122-160
Assess
TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3lqi.3.Amonomer0.671566-1784
ALA;ZN;100.00
Assess
2fsa.3.Amonomer0.571566-1765
ZN;20.61
Assess

MLL cleavage product C180 2719-3969; PRO_0000390950

DescriptionPDB IDOligo-stateRangeLigands
Cryo-EM structure of human MLL1-NCP complex, binding mode2 Heteromer
P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3;
3764-3969
SAH;ZN;
Assess
Cryo-EM structure of human MLL1-ubNCP complex (3.2 angstrom) Heteromer
P02281; P06897; P61964; P62799; P62979; P84233; Q15291; Q9UBL3;
3764-3969
SAH;ZN;LYS;GLN;
Assess
Cryo-EM structure of human MLL1-ubNCP complex (4.0 angstrom) Heteromer
P02281; P06897; P61964; P62799; P62979; P84233; Q15291; Q9UBL3;
3764-3969
SAH;ZN;
Assess
Cryo-EM structure of human MLL1-NCP complex, binding mode1 Heteromer
P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3;
3764-3969
SAH;ZN;LYS;GLN;
Assess
Cryo-EM structure of MLL1-NCP (H3K4M) complex, mode01 Heteromer
P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3;
3764-3969
Assess
Ternary Complex of the Mixed Lineage Leukaemia (MLL1) SET Domain with the cofactor product S-Adenosā€¦ Heteromer
P68433;
3790-3969
ZN;SAH;GOL;
Assess
Crystal structure of the MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L complex Heteromer
Q15291; Q9UBL3;
3813-3969
SAH;ZN;
Assess
The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me1 peptide Heteromer
Q15291; Q6NXT2; Q9UBL3;
3813-3969
SAH;ZN;
Assess
The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me2 peptide Heteromer
Q15291; Q6NXT2; Q9UBL3;
3813-3969
SAH;ZN;
Assess
The crystal structure of MLL1 (N3861I/Q3867L) in complex with RbBP5 and Ash2L Heteromer
Q15291; Q9UBL3;
3814-3969
SAH;ZN;
Assess
The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me0 peptide Heteromer
Q15291; Q6NXT2; Q9UBL3;
3814-3969
SAH;ZN;
Assess
Cryo-EM structure of MLL1 in complex with RbBP5 and WDR5 bound to the nucleosome Heteromer
P02281; P06897; P61964; P62799; P84233; Q15291;
3814-3969
SAH;ZN;
Assess
Cryo-EM structure of MLL1 core complex bound to the nucleosome Heteromer
P02281; P06897; P61964; P62799; P84233; Q15291; Q9C005; Q9UBL3;
3814-3969
SAH;ZN;
Assess
Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Claā€¦ Heteromer
P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3;
3814-3969
Assess
Cryo-EM structure of MLL1-NCP (H3K4M) complex, mode02 Heteromer
P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3;
3814-3969
Assess
Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Claā€¦ Heteromer
P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3;
3814-3969
Assess
Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Claā€¦ Heteromer
P02281; P06897; P61964; P62799; P84233; Q15291; Q9UBL3;
3815-3969
Assess
Crystal structure of the Mixed Lineage Leukaemia (MLL1) SET Domain with the cofactor product S-Adenā€¦ Heteromer
Q53HL2;
3822-3945
ZN;SAH;
Assess
Structural basis for cooperative transcription factor binding to the CBP coactivator Heteromer
P06876; P45481;
2839-2869
Assess
Crystal structure of the KIX domain of CBP in complex with a MLL/c-Myb chimera Heteromer
P01103; Q92793;
2843-2869
GOL;CL;
Assess
Allosteric communication in the KIX domain proceeds through dynamic re-packing of the hydrophobic cā€¦ Heteromer
Q92793;
2840-2858
Assess
Allosteric communication in the KIX domain proceeds through dynamic re-packing of the hydrophobic cā€¦ Heteromer
P16220; Q92793;
2840-2858
Assess
X-ray structure of WDR5-MLL1 Win motif peptide binary complex Heteromer
P61964;
3755-3770
Assess
Structure of WDR5 bound to MLL1 peptide Heteromer
P61964;
3762-3770
SO4;
Assess
Structural and biochemical insights into MLL1 core complex assembly and regulation. Heteromer
P61964; Q15291;
3762-3770
Assess
Structural basis of WDR5-MLL interaction Heteromer
P61964;
3764-3769
SO4;
Assess
Binary Complex of the Mixed Lineage Leukaemia (MLL1) SET Domain with the cofactor product S-Adenosyā€¦monomer3793-3969
ZN;SAH;
Assess
The Crystal Structure of MLL1 SET domain with N3816I/Q3867L mutationmonomer3814-3969
ZN;SAH;
Assess
MLL1 SET N3861I/Q3867L bound to inhibitor 18 (TC-5153)monomer3813-3968
ZN;Q2V;
Assess
MLL1 SET N3861I/Q3867L bound to inhibitor 12 (TC-5140)monomer3813-3968
ZN;Q2P;
Assess
MLL1 SET N3861I/Q3867L bound to inhibitor 14 (TC-5139)monomer3814-3968
Q34;ZN;
Assess
MLL1 SET N3861I/Q3867L bound to inhibitor 16 (TC-5109)monomer3814-3968
ZN;Q2M;
Assess
TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5jjy.1.Amonomer0.623816-3969
ZN;32.03
Assess
6kiu.1.Kmonomer0.593764-3969
ZN;LYS;100.00
Assess

8 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23lqh.1.Amonomer0.671528-1740
ZN;100.00
Assess
Isoform 25jjy.1.Amonomer0.623778-3931
ZN;32.03
Assess
Isoform 26kiu.1.Kmonomer0.593726-3931
ZN;LYS;100.00
Assess
Isoform 22ri7.1.Amonomer0.561528-1728
ZN;20.61
Assess
Isoform 33lqh.1.Amonomer0.661566-1781
ZN;100.00
Assess
Isoform 35jle.1.Amonomer0.593819-3971
ZN;32.03
Assess
Isoform 36kiu.1.Kmonomer0.583767-3972
ZN;LYS;100.00
Assess
Isoform 36aze.1.Amonomer0.531566-1768
ZN;21.95
Assess